Cian Healthcare Ltd.
| BSE: 542678 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE05BN01019 |
| BSE 00:00 | 21 Oct | 12.00 |
0 (0.00%) |
OPEN
12.00 |
HIGH
12.00 |
LOW
12.00 |
| NSE 05:30 | 01 Jan | Cian Healthcare Ltd |
| OPEN | 12.00 |
| PREVIOUS CLOSE | 12.00 |
| VOLUME | 2000 |
| 52-Week high | 27.50 |
| 52-Week low | 10.25 |
| P/E | |
| Mkt Cap.(Rs cr) | 28 |
| Buy Price | 11.40 |
| Buy Qty | 2000.00 |
| Sell Price | 12.20 |
| Sell Qty | 2000.00 |
Cian Healthcare Ltd. (CIANHEALTHCARE) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 463.35 | -7.35 | -1.56 | 3211.14 |
| Dr Reddy's Labs | 4949.80 | -150.50 | -2.95 | 2937.70 |
| Cipla | 765.15 | -5.30 | -0.69 | 2318.17 |
| Aurobindo Pharma | 775.95 | -18.75 | -2.36 | 1872.74 |
| Cadila Health. | 418.45 | -4.75 | -1.12 | 1412.90 |
| Divi's Lab. | 3134.70 | -21.60 | -0.68 | 1372.71 |
| Glenmark Pharma. | 479.15 | -6.00 | -1.24 | 1354.55 |
| Alkem Lab | 2684.20 | 0.35 | 0.01 | 1264.42 |
| Alembic Pharma | 962.85 | 1.95 | 0.20 | 969.40 |
| Torrent Pharma. | 2545.55 | -55.00 | -2.11 | 938.51 |
| P & G Health Ltd | 5117.65 | 6.75 | 0.13 | 838.72 |
| Lupin | 940.40 | -16.00 | -1.67 | 727.55 |
| Ipca Labs. | 2334.95 | -40.55 | -1.71 | 652.46 |
| Abbott India | 15296.65 | -268.15 | -1.72 | 592.93 |
| Fortis Health. | 126.25 | 2.30 | 1.86 | 513.33 |
| Pfizer | 5084.55 | -53.25 | -1.04 | 509.13 |
| Natco Pharma | 928.00 | 13.10 | 1.43 | 474.50 |
| Apollo Hospitals | 2080.30 | -37.80 | -1.78 | 470.30 |
| Granules India | 378.20 | -6.25 | -1.63 | 444.07 |
| Ajanta Pharma | 1589.55 | 18.50 | 1.18 | 441.13 |
Quick Links for Cian Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
